Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shail Verma

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|October 19, 2004
Maximizing clinical benefit with trastuzumabRichard Bell, Shail Verma, Michael Untch, et al.
Journal of Psychosocial Oncology|July 2, 2011
Trust in physician in relation to blame, regret, and depressive symptoms among women with a breast cancer experienceSheena Aislinn Taha, Kimberly Matheson, Lise Paquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2003
Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxelBrian Leyland-Jones, Karen Gelmon, Jean-Pierre Ayoub, et al.
Sarcoma|January 26, 2007
A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue SarcomaDon G Morris, Vivien H C Bramwell, Robert Turcotte, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|October 19, 2004
Maximizing clinical benefit with trastuzumabRichard Bell, Shail Verma, Michael Untch, et al.
Journal of Psychosocial Oncology|July 2, 2011
Trust in physician in relation to blame, regret, and depressive symptoms among women with a breast cancer experienceSheena Aislinn Taha, Kimberly Matheson, Lise Paquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2003
Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxelBrian Leyland-Jones, Karen Gelmon, Jean-Pierre Ayoub, et al.
Sarcoma|January 26, 2007
A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue SarcomaDon G Morris, Vivien H C Bramwell, Robert Turcotte, et al.
Pageof 1